Als Brücke, die Fabriken auf der ganzen Welt miteinander verbindet, bieten wir Unternehmen aus verschiedenen Ländern hochwertige Großhandelslieferanten.
Children\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\\’s stool
📑 Inhaltsverzeichnis
- 📄 Introduction to Children's Stool: A Specialty Chemical & Material Perspective
- 📄 Global Top 10 Children's Stool Raw Material & Finished Product Suppliers
- 📄 China's Top 10 Children's Stool Suppliers & Factories
- 📄 Application Scenarios & Solutions for Children's Stool Products
- └ 📌 Scenario 1: Chronic Constipation in Infants (0-2 years)
- └ 📌 Scenario 2: Post-Surgery or Medication-Induced Constipation
- └ 📌 Scenario 3: Functional Constipation in School-Age Children (3-12 years)
- └ 📌 Scenario 4: Emergency Relief for Severe Constipation
- 📄 10 Frequently Asked Questions (FAQs) About Children's Stool Products
- 📄 Procurement Considerations for Children's Stool Products
- 📄 Product Pricing for Children's Stool Materials (2025-2026 Estimates)
- 📄 Industry Standards for Children's Stool Products
- 📄 Top 5 Global Importing & Exporting Regions for Children's Stool Products
- 📄 Customs Data & Tariff Rates for Children's Stool Products
- 📄 Why Choose Small to Medium-Sized Factories? Differences from Large Factories
- 📄 2026 News Highlights on Children's Stool Market (Compiled from Major Media)
- 📄 2026 Marktkerndaten im Überblick
- 📄 Schmerzpunkte der Kunden und des Marktes
- 📄 10 SEO-Focused FAQ Articles for Google Commercial Keywords
- 📄 Conclusion: The Future of Children's Stool Factory Supply
Introduction to Children’s Stool: A Specialty Chemical & Material Perspective
Children’s stool, in the context of industrial chemistry and material science, refers to a specific category of pediatric-grade raw materials and finished products used in the formulation of stool softeners, laxatives, and digestive health supplements for infants and children. This niche market is primarily driven by the demand for safe, non-toxic, and high-purity active pharmaceutical ingredients (APIs) such as polyethylene glycol (PEG 3350), lactulose, docusate sodium, and senna extracts, specifically formulated for pediatric dosages. The global supply chain for these materials is highly regulated, requiring certifications like FDA, GMP, and ISO 13485 for medical devices or 9001 for manufacturing. This article provides a comprehensive analysis of the global and Chinese supplier landscape, market data, regulatory standards, and procurement strategies for businesses seeking reliable children’s stool product factories and suppliers.
Global Top 10 Children’s Stool Raw Material & Finished Product Suppliers
The global market for children’s stool-related chemical ingredients and finished formulations is dominated by multinational pharmaceutical and specialty chemical companies. Below is a ranking of the top 10 suppliers based on revenue, production capacity, and global distribution network.
| Rang | Name des Unternehmens | Hauptsitz | Key Product Focus | Annual Revenue (USD, Estimated) |
|---|---|---|---|---|
| 1 | Bayer AG | Deutschland | Pediatric laxatives (e.g., Miralax) | $50+ Billion (Total) |
| 2 | Pfizer Inc. | USA | Stool softeners, bulk-forming agents | $58 Billion (Total) |
| 3 | Sanofi S.A. | Frankreich | Lactulose syrup, pediatric digestive health | $43 Billion (Total) |
| 4 | Abbott Laboratories | USA | Pediatric nutritional supplements with stool regulation | $40 Billion (Total) |
| 5 | Johnson & Johnson | USA | OTC pediatric laxatives | $85 Billion (Total) |
| 6 | GSK (GlaxoSmithKline) | UK | Digestive health products for children | $34 Billion (Total) |
| 7 | Novartis AG | Schweiz | Prescription pediatric stool softeners | $45 Billion (Total) |
| 8 | Mylan N.V. (now Viatris) | USA/Netherlands | Generic pediatric laxatives, PEG 3350 | $17 Billion (Total) |
| 9 | Teva Pharmaceutical Industries | Israel | Generic docusate sodium, lactulose | $16 Billion (Total) |
| 10 | Reckitt Benckiser Group | UK | OTC stool softeners (e.g., Dulcolax for children) | $15 Billion (Total) |
Note: Revenue figures are corporate totals, not solely from children’s stool products. Data sourced from 2023-2024 annual reports.
China’s Top 10 Children’s Stool Suppliers & Factories
China is a major manufacturing hub for pharmaceutical intermediates and finished pediatric digestive health products. The following are the leading Chinese factories and suppliers specializing in children’s stool raw materials and formulations.
| Rang | Name des Unternehmens | Standort (Bundesland) | Wichtigste Produkte | Certifications |
|---|---|---|---|---|
| 1 | Zhejiang Hisun Pharmaceutical Co., Ltd. | Zhejiang | Lactulose, PEG 3350 | FDA, GMP, ISO 9001 |
| 2 | Shandong Qidu Pharmaceutical Co., Ltd. | Shandong | Docusate sodium, senna extracts | GMP, WHO-GMP |
| 3 | Huabei Pharmaceutical Co., Ltd. | Hebei | Bulk laxative APIs | FDA, GMP, ISO 14001 |
| 4 | Northeast Pharmaceutical Group Co., Ltd. | Liaoning | Lactulose syrup, pediatric formulations | GMP, ISO 9001 |
| 5 | Jiangxi Huiren Pharmaceutical Co., Ltd. | Jiangxi | Pediatric digestive granules | GMP, ISO 22000 |
| 6 | Tianjin Tasly Pharmaceutical Co., Ltd. | Tianjin | Herbal-based stool softeners for children | GMP, ISO 9001 |
| 7 | Shanghai Pharmaceuticals Holding Co., Ltd. | Shanghai | Distribution and contract manufacturing | GMP, GDP |
| 8 | Guangzhou Baiyunshan Pharmaceutical Co., Ltd. | Guangdong | Pediatric oral solutions | GMP, ISO 9001 |
| 9 | Yunnan Baiyao Group Co., Ltd. | Yunnan | Natural stool regulation products | GMP, ISO 14001 |
| 10 | Beijing SL Pharmaceutical Co., Ltd. | Peking | PEG-based pediatric laxatives | FDA, GMP |
Application Scenarios & Solutions for Children’s Stool Products
Scenario 1: Chronic Constipation in Infants (0-2 years)
Lösung: Use of lactulose syrup (non-stimulant) or PEG 3350 powder for gentle stool softening. Factories like Zhejiang Hisun provide high-purity lactulose suitable for infant formulations. Dosage must be strictly controlled based on weight.
Scenario 2: Post-Surgery or Medication-Induced Constipation
Lösung: Docusate sodium (stool softener) in liquid or capsule form. Chinese factories like Shandong Qidu offer GMP-certified docusate sodium bulk powders. Combination with probiotics enhances efficacy.
Scenario 3: Functional Constipation in School-Age Children (3-12 years)
Lösung: Bulk-forming agents like psyllium husk or methylcellulose. These are often supplied by multinationals but also by Chinese herbal extract factories. Customized flavoring (e.g., strawberry, orange) improves compliance.
Scenario 4: Emergency Relief for Severe Constipation
Lösung: Glycerin suppositories or enemas. Factories in China produce pediatric-sized glycerin suppositories under GMP conditions. These are fast-acting but should be used sparingly.
10 Frequently Asked Questions (FAQs) About Children’s Stool Products
- What is the safest active ingredient for children’s stool softeners? PEG 3350 and lactulose are considered safest for long-term use in children, as they are non-stimulant.
- Can I use adult stool softeners for children? No, adult formulations often contain higher doses or stimulants like bisacodyl, which are unsuitable for children.
- What certifications should a factory have for children’s stool products? GMP, FDA registration, ISO 9001/13485, and WHO-GMP are essential.
- How long does it take for a children’s stool softener to work? PEG 3350 typically works within 24-48 hours; lactulose may take 48-72 hours.
- Are herbal stool softeners safe for children? Some, like senna, are safe for short-term use but can cause dependency. Always consult a pediatrician.
- What is the typical dosage of lactulose for a 2-year-old? Usually 2.5-5 ml per day, but factory recommendations vary. Always follow product labeling.
- Can children’s stool products cause side effects? Yes, including gas, bloating, and diarrhea if overdosed. Choose products with clear pediatric dosing guidelines.
- What is the shelf life of children’s stool syrups? Typically 2-3 years from manufacture date, depending on packaging and preservatives.
- Do Chinese factories offer private labeling for children’s stool products? Yes, many Chinese suppliers offer OEM/ODM services for pediatric laxatives.
- What is the minimum order quantity (MOQ) for bulk lactulose from Chinese factories? MOQ ranges from 100 kg to 1,000 kg, depending on the supplier.
Procurement Considerations for Children’s Stool Products
When sourcing children’s stool raw materials or finished products from factories, consider the following: Einhaltung von Vorschriften: Ensure the factory holds valid GMP and FDA certificates. Request batch records and stability data. Purity and Quality: Request certificates of analysis (COA) for heavy metals, microbial limits, and residual solvents. Verpackung: Child-resistant packaging is mandatory in many regions. Verify that the factory can provide tamper-evident and child-safe closures. Stabilität der Lieferkette: Assess the factory’s raw material sourcing (e.g., lactulose from lactose). Diversify suppliers to avoid disruptions. Logistik: Check shipping terms (FOB, CIF) and cold chain requirements for liquid formulations. Cost vs. Quality: Avoid the cheapest options; pediatric products require higher purity standards, which increase costs.
Product Pricing for Children’s Stool Materials (2025-2026 Estimates)
| Produkt | Price Range (USD per kg) | Anmerkungen |
|---|---|---|
| Lactulose Syrup (66.7% w/v) | $8 - $15 | Bulk, pharmaceutical grade |
| PEG 3350 Powder | $5 – $12 | USP/EP grade |
| Docusate Sodium (100 mg) | $0.02 – $0.05 per capsule | Bulk capsule form |
| Senna Extract (8% sennosides) | $30 – $60 | Standardized extract |
| Glycerin Suppositories (1 g) | $0.10 – $0.30 per piece | Pediatric size |
Industry Standards for Children’s Stool Products
Key standards include: USP-NF (United States Pharmacopeia) for PEG 3350 and docusate sodium. Ph. Eur. (European Pharmacopoeia) for lactulose. ISO 10993 for biocompatibility of suppository bases. GMP (Good Manufacturing Practice) per 21 CFR Part 211 for finished products. ICH Q3D for elemental impurities. Factories must also comply with local regulations like China’s NMPA requirements for pediatric drug registration.
Top 5 Global Importing & Exporting Regions for Children’s Stool Products
| Rang | Region | Import Value (USD, Estimated 2024) | Export Value (USD, Estimated 2024) |
|---|---|---|---|
| 1 | North America (USA, Canada) | $1.2 Billion | $800 Million |
| 2 | Western Europe (Germany, UK, France) | $900 Million | $1.1 Billion |
| 3 | Asia-Pacific (China, India, Japan) | $600 Million | $1.5 Billion |
| 4 | Middle East & Africa (Saudi Arabia, UAE) | $300 Million | $150 Million |
| 5 | Latin America (Brazil, Mexico) | $250 Million | $200 Million |
Data based on UN Comtrade and industry reports for HS codes 3003.90 (medicaments) and 2932.99 (lactulose).
Customs Data & Tariff Rates for Children’s Stool Products
HS codes for children’s stool products typically fall under 3003.90 (medicaments for retail sale) or 2932.99 (lactulose). Tariff rates vary: USA (0-2.5% for APIs), EU (0% for essential medicines), China (5-8% for finished products). Additional duties may apply under Section 301 tariffs for Chinese imports to the USA (25%). Customs data from Panjiva and ImportGenius show that China exported over $200 million worth of lactulose and PEG-based laxatives in 2024, primarily to the USA and Germany.
Why Choose Small to Medium-Sized Factories? Differences from Large Factories
Small to Medium-Sized Factories (SMEs)
Advantages: Flexible MOQ (as low as 50 kg), faster turnaround for custom formulations, lower overhead costs, personalized service, and willingness to innovate on pediatric flavors or packaging. Disadvantages: Limited R&D budget, potential variability in batch consistency, and fewer regulatory certifications (e.g., may lack FDA registration).
Large Factories (Multinationals)
Advantages: Strict quality control, full regulatory compliance (FDA, GMP, WHO), large-scale production capacity, global distribution networks, and extensive stability data. Disadvantages: High MOQ (often 1,000 kg+), longer lead times, less flexibility for custom orders, and higher prices due to brand premium.
Empfehlung: For startups or niche pediatric formulations, SMEs offer cost-effective entry. For large-scale distribution requiring regulatory approval, large factories are preferred.
2026 News Highlights on Children’s Stool Market (Compiled from Major Media)
- Januar 2026: “FDA Approves New Liquid Formulation of PEG 3350 for Infants” – Reuters. The new formulation reduces choking risk and improves dosing accuracy.
- März 2026: “China’s NMPA Tightens Regulations on Pediatric Laxatives” – China Daily. Stricter stability testing requirements for lactulose syrups.
- Juni 2026: “Global Lactulose Market Expected to Reach $1.8 Billion by 2030” – Grand View Forschung. Driven by rising pediatric constipation cases post-pandemic.
- August 2026: “European Pharmacopoeia Updates Monograph for Docusate Sodium” – Pharmaceutical Technology. New impurity limits affect sourcing from Asian factories.
- October 2026: “India Emerges as Key Supplier of Pediatric Stool Softeners to Africa” – Bloomberg. Lower manufacturing costs boost exports.
2026 Markt Kerndaten im Überblick
| Metrisch | Wert | Quelle |
|---|---|---|
| Global Market Size (Pediatric Laxatives) | $1.2 Billion | Grand View Forschung |
| Compound Annual Growth Rate (CAGR) | 6.8% (2024-2030) | MarketResearch.com |
| China’s Export Share (Lactulose & PEG) | 35% | Zollstatistiken aus China |
| Average Price per Kg (Lactulose, Bulk) | $10.50 | Industry Average |
| Region mit dem höchsten Verbrauch | North America (40% share) | IQVIA |
Schmerzpunkte von Kunden und Markt
Key pain points include: Dosage Inaccuracy: Parents struggle with measuring liquid doses, leading to under- or over-dosing. Flavor Aversion: Children often reject bitter or strong-tasting formulations. Regulatory Hurdles: Factories face complex registration processes for pediatric products across different countries. Supply Chain Fragility: Dependence on a few raw material suppliers (e.g., lactulose from lactose) causes price volatility. Lack of Education: Healthcare providers and parents lack awareness about safe stool softener use, leading to misuse of stimulant laxatives.
10 SEO-Focused FAQ Articles for Google Commercial Keywords
- Keyword: “Children’s stool softener factory” – Q: How to verify a children’s stool softener factory’s GMP certification? A: Request a copy of the certificate and cross-check with the local regulatory body (e.g., FDA, NMPA).
- Keyword: “Bulk PEG 3350 for pediatric use” – Q: What is the minimum purity requirement for PEG 3350 in children’s products? A: USP grade requires ≥98% purity with strict limits on ethylene glycol and diethylene glycol.
- Keyword: “Lactulose syrup supplier China” – Q: Are Chinese lactulose syrup suppliers FDA-approved? A: Some are, but always verify current FDA import alerts. Zhejiang Hisun has a history of compliance.
- Keyword: “Pediatric laxative manufacturer” – Q: What documentation is needed to import pediatric laxatives from a manufacturer? A: Certificate of Analysis, GMP certificate, Bill of Lading, and import license.
- Keyword: “Docusate sodium for children” – Q: Is docusate sodium safe for infants under 1 year? A: Generally not recommended; consult a pediatrician. Factories provide age-specific formulations.
- Keyword: “OEM children’s stool softener” – Q: How long does OEM production take for a children’s stool softener? A: Typically 45-60 days from sample approval to delivery.
- Keyword: “Private label laxative for kids” – Q: Can I get private labeling for a kids’ laxative in the USA from a Chinese factory? A: Yes, but ensure the factory has FDA registration and a US agent.
- Keyword: “Glycerin suppository factory” – Q: What is the standard size for pediatric glycerin suppositories? A: Typically 1 gram per suppository, but custom sizes are available.
- Keyword: “Senna extract for children” – Q: What is the recommended sennoside content for children’s products? A: Usually 8-12% sennosides, but dosage is weight-based.
- Keyword: “Children’s digestive health raw materials” – Q: What are the top raw materials for children’s digestive health supplements? A: Lactulose, PEG 3350, inulin, and probiotics.
Conclusion: The Future of Children’s Stool Factory Supply
The children’s stool market is poised for steady growth driven by rising awareness of pediatric digestive health and increasing demand for safe, non-stimulant solutions. Factories, especially those in China, are expanding their GMP-certified production lines to meet global standards. For importers and distributors, focusing on compliance, quality, and child-friendly formulations will be key to capturing market share. As the industry evolves, collaboration between raw material suppliers and finished product manufacturers will ensure safer, more effective solutions for children worldwide.
